Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign?

Title Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign?
Authors Parente DN1, Kluijfhout WP1, Bongers PJ1, Verzijl R1, Devon KM1,2, Rotstein LE1, Goldstein DP3, Asa SL4, Mete O4, Pasternak JD.
Affiliation 1. Division of General Surgery, University Health Network, Toronto General Hospital, 200 Elizabeth St. Room 10EN-214, Toronto, ON, M5G 2C4, Canada.

2. Department of Surgery, Womens College Hospital, Toronto, ON, Canada.

3. Otolaryngology Head and Neck Surgery, University Health Network, 610 University Ave. Room 3-952, Toronto, ON, M5G 2M9, Canada.

4. Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada.

5. Division of General Surgery, University Health Network, Toronto General Hospital, 200 Elizabeth St. Room 10EN-214, Toronto, ON, M5G 2C4, Canada. jesse.pasternak@uhn.ca
Journal World J Surg 2018;42:321-326.
content
(³»¿ë ¿ä¾à)
¡°À¯µÎ¾Ï ¼¼Æ÷ÇÙÀº °¡Áø ºñħ½À°©»ó¼±¿©Æ÷Á¾¾ç (NIFTP)¡±Àº °©»ó¼± À¯µÎ¾Ï Áß ¾Ï¼¼Æ÷¿Í ¸ð¾çÀº ºñ½ÁÇÏÁö¸¸ ¼ºÁúÀÌ ´Þ¶ó ¿¹ÈÄ°¡ ÁÁÀº ÇüŸ¦ ÀçºÐ·ùÇÏ¿© »õ·Î¿î À̸§À¸·Î ¸í¸íÇÑ °ÍÀ¸·Î, 2017³â °³Á¤µÈ WHO Á¾¾ç ºÐ·ù¹ý¿¡ ¹Ý¿µµÇ¾ú´Ù.
NIFTPÀÇ ¹ßº´·üÀº 16-23%·Î º¸°íµÇ¾úÀ¸³ª, ±âÁ¸ÀÇ °©»ó¼± À¯µÎ¾Ï Áß NIFTP·Î ÀçºÐ·ùÇÔÀ¸·Î½á ¾òÀ» ¼ö ÀÖ´Â Àå±âÀûÀÎ È¿°ú¿¡ ´ëÇؼ­´Â ¾ÆÁ÷ ¿¬±¸°¡ ÀÌ·ç¾îÁöÁö ¾Ê°í ÀÖ´Ù.
º» ¿¬±¸¿¡¼­ ÀúÀÚµéÀº ÀúÀÚµéÀÇ ±â°ü¿¡¼­ NIFTPÀÇ ¹ß»ý·üÀ» È®ÀÎÇÏ°í, ±×°ÍÀÌ ÁøÁ¤À¸·Î ¾ç¼ºÁ¾¾çÀ¸·Î ºÐ·ùµÇ¾î¾ß ÇÏ´ÂÁö¸¦ È®ÀÎÇÏ°íÀÚ ÇÏ¿´´Ù.

ÀúÀÚµéÀÇ ±â°ü¿¡¼­ 2004³âºÎÅÍ 2013³â±îÁö °©»ó¼± ÀýÁ¦¼úÀ» ¹ÞÀº ȯÀÚµé Áß °©»ó¼± À¯µÎ¾ÏÀ¸·Î Áø´ÜµÈ ȯÀÚÀÇ º´¸® °Ë»ç °á°ú¸¦ ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. ÀÌ Áß 102¸íÀÇ È¯ÀÚ°¡ NIFTP·Î Áø´ÜµÇ¾î, 2.1%ÀÇ ¹ßº´·üÀ» º¸¿´´Ù.
102¸í Áß 77%°¡ ¿©¼ºÀ̾ú°í Æò±Õ ¿¬·ÉÀº 48.6¼¼¿´´Ù. °©»ó¼± ÀüÀýÁ¦¼úÀ» ¹ÞÀº ȯÀÚ´Â 77.8%¿´°í ¹æ»ç¼º ¿ä¿Àµå Ä¡·á¸¦ ¹ÞÀº ȯÀÚ´Â 45¸í(44%)À̾ú´Ù. 102¸íÀÇ È¯ÀÚ Áß, 6¸í(6%)¿¡¼­ ¾Ç¼º Á¾¾çÀÇ Çൿ¾ç½ÄÀ» º¸¿´´Ù (°æºÎ ¸²ÇÁÀý ÀüÀÌ 5¸í, ÆóÀüÀÌ 1¸í).

°á·ÐÀûÀ¸·Î, ÀÌ ¿¬±¸¿¡¼­ NIFTPÀÇ Àüü ¹ßº´·üÀº ±âÁ¸ÀÇ º¸°íº¸´Ù ³·°Ô º¸°íµÇ¾ú´Ù. ÇÏÁö¸¸, ¼Ò¼öÀÌÁö¸¸ ¾Ç¼º Á¾¾çÀÇ Çൿ¾ç½ÄÀ» º¸ÀÌ´Â °æ¿ì°¡ ÀÖÀ¸¹Ç·Î ÀÓ»óÀÇ´Â À̸¦ °£°úÇؼ­´Â ¾ÈµÈ´Ù.
Clinical
importance
NIFTP´Â º¸°íµÈ ¹Ù¿Í´Â ´Þ¸® ³·Àº ¹ßº´·ü¸¦ º¸ÀδÙ. NIFTPÀÇ ¿¹ÈÄ´Â ¸Å¿ì ÁÁÀ¸³ª, °£È¤ ¾Ç¼º Á¾¾çÀÇ Çൿ¾ç½ÄÀ» º¸ÀÌ´Â °æ¿ì°¡ ¹ß°ßµÇ¹Ç·Î, NIFTP·Î Áø´ÜµÈ ȯÀڵ鿡¼­µµ ¾ÏÀÇ Àç¹ß ¿©ºÎ¸¦ ÁÖ±âÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â °ÍÀÌ ÇÊ¿äÇÏ´Ù.

¿¬¼¼´ëÇб³ °­³²¼¼ºê¶õ½ºº´¿ø ¿Ü°ú ÀÌ¿ë»ó